Clinical Trial

ANGiographic Evaluation of Left Main Coronary Artery INtErvention

Study acronym: ANGELINE
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 13, 2026 (before its estimated March 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
To assess if an angiographic follow-up at 6 months after Percutaneous Coronary Intervention in Left Main Coronary Artery Disease decrease the composite objective of death, myocardial infarction, and stroke at 36 months.
Protocol Amendment History 26 amendments
This ClinicalTrials.gov record has been amended 26 times since 2020-10-21; most recent amendment 2026-02-12.
Status change: Recruiting → Active, Not Recruiting 2025-03-03
Status change: Not Yet Recruiting → Recruiting 2021-03-08
Trial Details
NCT Number NCT04604197
Lead Sponsor Fundación EPIC
Conditions Coronary Occlusion, Left Main Coronary Artery Disease, Coronary Artery Stenosis, Coronary Disease, Coronary Artery Disease
Enrollment 400 participants
Start Date 2021-04-16
Primary Completion 2026-03-01 (estimated)
Study Completion 2026-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-13